The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemo or chemo-free regimens in heavily pretreated multiple myeloma? Role of bendamustine-bortezomib-dexamethasone (BVD) in NOVEL agents' era.
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; Astellas Oncology; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; GlycoMimetics; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Astellas Oncology; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; GlycoMimetics; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
 
Lucio Catalano
No Relationships to Disclose
 
Davide Nappi
No Relationships to Disclose
 
Sonia Ronconi
No Relationships to Disclose
 
Delia Cangini
No Relationships to Disclose
 
Michela Ceccolini
No Relationships to Disclose
 
Gerardo Musuraca
No Relationships to Disclose
 
Giovanni Martinelli
No Relationships to Disclose